Global Intravenous (IV) Solutions Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 14-Sep-2018
No. of pages: 118

Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation.

Scope of the Report:

This report focuses on the Intravenous (IV) Solutions in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Key factors driving market expansion include the rapidly increasing natality rate including a high percentage of premature births and malnutrition.

The worldwide market for Intravenous (IV) Solutions is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

-ICU Medical Inc. (U.S.)

-B. Braun Melsungen AG (Germany)

-Fresenius Kabi AG (Germany)

-Baxter (U.S.)

-Amanta Healthcare (India)

-Terumo Medical Corporation (Tokyo)

-Grifols S.A. (Spain)

Market Segment by Regions, regional analysis covers

-North America (United States, Canada and Mexico)

-Europe (Germany, France, UK, Russia and Italy)

-Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

-South America (Brazil, Argentina, Colombia etc.)

-Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

-Peripheral Parenteral Nutrition

-Total Parenteral Nutrition

Market Segment by Applications, can be divided into

-Hospital & Clinics

-Ambulatory

-Home Care

There are 15 Chapters to deeply display the global Intravenous (IV) Solutions market.

Chapter 1, to describe Intravenous (IV) Solutions Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Intravenous (IV) Solutions, with sales, revenue, and price of Intravenous (IV) Solutions, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Intravenous (IV) Solutions, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Intravenous (IV) Solutions market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Intravenous (IV) Solutions sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Intravenous (IV) Solutions Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Intravenous (IV) Solutions Introduction
1.2 Market Analysis by Type
1.2.1 Peripheral Parenteral Nutrition
1.2.2 Total Parenteral Nutrition
1.3 Market Analysis by Applications
1.3.1 Hospital & Clinics
1.3.2 Ambulatory
1.3.3 Home Care
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ICU Medical Inc. (U.S.)
2.1.1 Business Overview
2.1.2 Intravenous (IV) Solutions Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 B. Braun Melsungen AG (Germany)
2.2.1 Business Overview
2.2.2 Intravenous (IV) Solutions Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Fresenius Kabi AG (Germany)
2.3.1 Business Overview
2.3.2 Intravenous (IV) Solutions Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Baxter (U.S.)
2.4.1 Business Overview
2.4.2 Intravenous (IV) Solutions Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Baxter (U.S.) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Amanta Healthcare (India)
2.5.1 Business Overview
2.5.2 Intravenous (IV) Solutions Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Terumo Medical Corporation (Tokyo)
2.6.1 Business Overview
2.6.2 Intravenous (IV) Solutions Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Grifols S.A. (Spain)
2.7.1 Business Overview
2.7.2 Intravenous (IV) Solutions Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Intravenous (IV) Solutions Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Intravenous (IV) Solutions Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Intravenous (IV) Solutions Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Intravenous (IV) Solutions Manufacturer Market Share in 2017
3.3.2 Top 6 Intravenous (IV) Solutions Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Intravenous (IV) Solutions Market Analysis by Regions
4.1 Global Intravenous (IV) Solutions Sales, Revenue and Market Share by Regions
4.1.1 Global Intravenous (IV) Solutions Sales and Market Share by Regions (2013-2018)
4.1.2 Global Intravenous (IV) Solutions Revenue and Market Share by Regions (2013-2018)
4.2 North America Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
4.3 Europe Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
4.5 South America Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
5 North America Intravenous (IV) Solutions by Countries
5.1 North America Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries
5.1.1 North America Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)
5.1.2 North America Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)
5.2 United States Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
5.3 Canada Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
5.4 Mexico Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
6 Europe Intravenous (IV) Solutions by Countries
6.1 Europe Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries
6.1.1 Europe Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)
6.2 Germany Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
6.3 UK Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
6.4 France Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
6.5 Russia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
6.6 Italy Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
7 Asia-Pacific Intravenous (IV) Solutions by Countries
7.1 Asia-Pacific Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)
7.2 China Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
7.3 Japan Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
7.4 Korea Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
7.5 India Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
8 South America Intravenous (IV) Solutions by Countries
8.1 South America Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries
8.1.1 South America Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)
8.1.2 South America Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
8.3 Argentina Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
8.4 Colombia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
9 Middle East and Africa Intravenous (IV) Solutions by Countries
9.1 Middle East and Africa Intravenous (IV) Solutions Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intravenous (IV) Solutions Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Intravenous (IV) Solutions Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
9.3 UAE Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
9.4 Egypt Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
9.5 Nigeria Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
9.6 South Africa Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
10 Global Intravenous (IV) Solutions Market Segment by Type
10.1 Global Intravenous (IV) Solutions Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Intravenous (IV) Solutions Sales and Market Share by Type (2013-2018)
10.1.2 Global Intravenous (IV) Solutions Revenue and Market Share by Type (2013-2018)
10.2 Peripheral Parenteral Nutrition Sales Growth and Price
10.2.1 Global Peripheral Parenteral Nutrition Sales Growth (2013-2018)
10.2.2 Global Peripheral Parenteral Nutrition Price (2013-2018)
10.3 Total Parenteral Nutrition Sales Growth and Price
10.3.1 Global Total Parenteral Nutrition Sales Growth (2013-2018)
10.3.2 Global Total Parenteral Nutrition Price (2013-2018)
11 Global Intravenous (IV) Solutions Market Segment by Application
11.1 Global Intravenous (IV) Solutions Sales Market Share by Application (2013-2018)
11.2 Hospital & Clinics Sales Growth (2013-2018)
11.3 Ambulatory Sales Growth (2013-2018)
11.4 Home Care Sales Growth (2013-2018)
12 Intravenous (IV) Solutions Market Forecast (2018-2023)
12.1 Global Intravenous (IV) Solutions Sales, Revenue and Growth Rate (2018-2023)
12.2 Intravenous (IV) Solutions Market Forecast by Regions (2018-2023)
12.2.1 North America Intravenous (IV) Solutions Market Forecast (2018-2023)
12.2.2 Europe Intravenous (IV) Solutions Market Forecast (2018-2023)
12.2.3 Asia-Pacific Intravenous (IV) Solutions Market Forecast (2018-2023)
12.2.4 South America Intravenous (IV) Solutions Market Forecast (2018-2023)
12.2.5 Middle East and Africa Intravenous (IV) Solutions Market Forecast (2018-2023)
12.3 Intravenous (IV) Solutions Market Forecast by Type (2018-2023)
12.3.1 Global Intravenous (IV) Solutions Sales Forecast by Type (2018-2023)
12.3.2 Global Intravenous (IV) Solutions Market Share Forecast by Type (2018-2023)
12.4 Intravenous (IV) Solutions Market Forecast by Application (2018-2023)
12.4.1 Global Intravenous (IV) Solutions Sales Forecast by Application (2018-2023)
12.4.2 Global Intravenous (IV) Solutions Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Intravenous (IV) Solutions Picture
Table Product Specifications of Intravenous (IV) Solutions
Figure Global Sales Market Share of Intravenous (IV) Solutions by Types in 2017
Table Intravenous (IV) Solutions Types for Major Manufacturers
Figure Peripheral Parenteral Nutrition Picture
Figure Total Parenteral Nutrition Picture
Figure Intravenous (IV) Solutions Sales Market Share by Applications in 2017
Figure Hospital & Clinics Picture
Figure Ambulatory Picture
Figure Home Care Picture
Figure United States Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure France Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure UK Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure China Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure India Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Intravenous (IV) Solutions Revenue (Value) and Growth Rate (2013-2023)
Table ICU Medical Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Type and Applications
Table ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table B. Braun Melsungen AG (Germany) Basic Information, Manufacturing Base and Competitors
Table B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Type and Applications
Table B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Fresenius Kabi AG (Germany) Basic Information, Manufacturing Base and Competitors
Table Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Type and Applications
Table Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Baxter (U.S.) Basic Information, Manufacturing Base and Competitors
Table Baxter (U.S.) Intravenous (IV) Solutions Type and Applications
Table Baxter (U.S.) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amanta Healthcare (India) Basic Information, Manufacturing Base and Competitors
Table Amanta Healthcare (India) Intravenous (IV) Solutions Type and Applications
Table Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Terumo Medical Corporation (Tokyo) Basic Information, Manufacturing Base and Competitors
Table Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Type and Applications
Table Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols S.A. (Spain) Basic Information, Manufacturing Base and Competitors
Table Grifols S.A. (Spain) Intravenous (IV) Solutions Type and Applications
Table Grifols S.A. (Spain) Intravenous (IV) Solutions Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Intravenous (IV) Solutions Sales by Manufacturer (2016-2017)
Figure Global Intravenous (IV) Solutions Sales Market Share by Manufacturer in 2016
Figure Global Intravenous (IV) Solutions Sales Market Share by Manufacturer in 2017
Table Global Intravenous (IV) Solutions Revenue by Manufacturer (2016-2017)
Figure Global Intravenous (IV) Solutions Revenue Market Share by Manufacturer in 2016
Figure Global Intravenous (IV) Solutions Revenue Market Share by Manufacturer in 2017
Figure Top 3 Intravenous (IV) Solutions Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Intravenous (IV) Solutions Manufacturer (Revenue) Market Share in 2017
Figure Global Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Global Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)
Table Global Intravenous (IV) Solutions Sales by Regions (2013-2018)
Table Global Intravenous (IV) Solutions Sales Market Share by Regions (2013-2018)
Table Global Intravenous (IV) Solutions Revenue by Regions (2013-2018)
Figure Global Intravenous (IV) Solutions Revenue Market Share by Regions in 2013
Figure Global Intravenous (IV) Solutions Revenue Market Share by Regions in 2017
Figure North America Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Europe Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure South America Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure North America Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)
Table North America Intravenous (IV) Solutions Sales by Countries (2013-2018)
Table North America Intravenous (IV) Solutions Sales Market Share by Countries (2013-2018)
Figure North America Intravenous (IV) Solutions Sales Market Share by Countries in 2013
Figure North America Intravenous (IV) Solutions Sales Market Share by Countries in 2017
Table North America Intravenous (IV) Solutions Revenue by Countries (2013-2018)
Table North America Intravenous (IV) Solutions Revenue Market Share by Countries (2013-2018)
Figure North America Intravenous (IV) Solutions Revenue Market Share by Countries in 2013
Figure North America Intravenous (IV) Solutions Revenue Market Share by Countries in 2017
Figure United States Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Canada Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Mexico Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Europe Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)
Table Europe Intravenous (IV) Solutions Sales by Countries (2013-2018)
Table Europe Intravenous (IV) Solutions Sales Market Share by Countries (2013-2018)
Table Europe Intravenous (IV) Solutions Revenue by Countries (2013-2018)
Figure Europe Intravenous (IV) Solutions Revenue Market Share by Countries in 2016
Figure Europe Intravenous (IV) Solutions Revenue Market Share by Countries in 2017
Figure Germany Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure UK Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure France Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Russia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Italy Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Intravenous (IV) Solutions Sales by Countries (2013-2018)
Table Asia-Pacific Intravenous (IV) Solutions Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Intravenous (IV) Solutions Sales Market Share by Countries 2017
Table Asia-Pacific Intravenous (IV) Solutions Revenue by Countries (2013-2018)
Figure Asia-Pacific Intravenous (IV) Solutions Revenue Market Share by Countries 2017
Figure China Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Japan Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Korea Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure India Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Southeast Asia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure South America Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)
Table South America Intravenous (IV) Solutions Sales by Countries (2013-2018)
Table South America Intravenous (IV) Solutions Sales Market Share by Countries (2013-2018)
Figure South America Intravenous (IV) Solutions Sales Market Share by Countries in 2017
Table South America Intravenous (IV) Solutions Revenue by Countries (2013-2018)
Table South America Intravenous (IV) Solutions Revenue Market Share by Countries (2013-2018)
Figure South America Intravenous (IV) Solutions Revenue Market Share by Countries in 2017
Figure Brazil Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Argentina Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Colombia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Intravenous (IV) Solutions Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Intravenous (IV) Solutions Sales by Countries (2013-2018)
Table Middle East and Africa Intravenous (IV) Solutions Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Intravenous (IV) Solutions Sales Market Share by Countries in 2017
Table Middle East and Africa Intravenous (IV) Solutions Revenue by Countries (2013-2018)
Table Middle East and Africa Intravenous (IV) Solutions Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Intravenous (IV) Solutions Revenue Market Share by Countries in 2013
Figure Middle East and Africa Intravenous (IV) Solutions Revenue Market Share by Countries in 2017
Figure Saudi Arabia Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure UAE Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Egypt Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure Nigeria Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Figure South Africa Intravenous (IV) Solutions Sales and Growth Rate (2013-2018)
Table Global Intravenous (IV) Solutions Sales by Type (2013-2018)
Table Global Intravenous (IV) Solutions Sales Share by Type (2013-2018)
Table Global Intravenous (IV) Solutions Revenue by Type (2013-2018)
Table Global Intravenous (IV) Solutions Revenue Share by Type (2013-2018)
Figure Global Peripheral Parenteral Nutrition Sales Growth (2013-2018)
Figure Global Peripheral Parenteral Nutrition Price (2013-2018)
Figure Global Total Parenteral Nutrition Sales Growth (2013-2018)
Figure Global Total Parenteral Nutrition Price (2013-2018)
Table Global Intravenous (IV) Solutions Sales by Application (2013-2018)
Table Global Intravenous (IV) Solutions Sales Share by Application (2013-2018)
Figure Global Ambulatory Sales Growth (2013-2018)
Figure Global Home Care Sales Growth (2013-2018)
Figure Global Intravenous (IV) Solutions Sales, Revenue and Growth Rate (2018-2023)
Table Global Intravenous (IV) Solutions Sales Forecast by Regions (2018-2023)
Table Global Intravenous (IV) Solutions Market Share Forecast by Regions (2018-2023)
Figure North America Sales Intravenous (IV) Solutions Market Forecast (2018-2023)
Figure Europe Sales Intravenous (IV) Solutions Market Forecast (2018-2023)
Figure Asia-Pacific Sales Intravenous (IV) Solutions Market Forecast (2018-2023)
Figure South America Sales Intravenous (IV) Solutions Market Forecast (2018-2023)
Figure Middle East and Africa Sales Intravenous (IV) Solutions Market Forecast (2018-2023)
Table Global Intravenous (IV) Solutions Sales Forecast by Type (2018-2023)
Table Global Intravenous (IV) Solutions Market Share Forecast by Type (2018-2023)
Table Global Intravenous (IV) Solutions Sales Forecast by Application (2018-2023)
Table Global Intravenous (IV) Solutions Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Bone Graft Substitute Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Bone substitutes can be broadly categorized into bone grafts (autograft, allograft, xenograft), ceramics (hydroxyapatite, TCP, calcium sulphate) and growth factors (DBM, PRP, BMP'S) Scope of the Report: The worldwide market for Bone Graft Substitute is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on the Bone ......
  • Global Oncology Adjuvants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 118
    Oncology Adjuvant treatment is a cancer therapy, which involves cancer treatment after the primary treatment is completed. Oncology adjuvants treatment mainly reduces the reoccurrence of cancer. Scope of the Report: The worldwide market for Oncology Adjuvants is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on......
  • Global Oncology Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 122
    Drugs used for oncology. Scope of the Report: The worldwide market for Oncology Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on the Oncology Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on ma......
  • Global Ophthalmic Viscosurgical Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Ophthalmic viscosurgical devices (OVDs) are used in cataract surgery as a viscoelastic solution to create and maintain space in the anterior chamber of the eye. OVDs have generally been used during phacoemulsification, implantation of intraocular lens, to protect corneal endothelium, and as a coating to surgical instruments. OVDs are transparent, gel like viscous substances having elastic properties. OVDs have properties of both fluids and solids. The differentiating feature in OVDs can be becau......
  • Global Oral Antidiabetic Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 122
    Diabetes mellitus is a group of a metabolic disorder caused when the body is unable to produce required quantity of Insulin. Insulin is a hormone secreted by beta cells of the islet of Langerhans of the pancreas. Various symptoms associated with diabetes disorder include recurrent urination, increased thirst, and hunger. Diabetes can cause much chronic complication if left untreated. Some of them include acute complications like diabetic ketoacidosis, chronic kidney failure, foot ulcers, and dam......
  • Global Polymerase Chain Reaction (PCR) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 124
    Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials. Scope of the Report: The worldwide market for Polymerase Chain Reaction (PCR) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Glo......
  • Global Parkinson's Disease Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 116
    Parkinson's disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors. Scope of the Report: The worldwide market for Parkinson's Disease Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. This report focuses on the Parkinson's Disease Therapeutics in global market, especially in ......
  • Global Pathology Imaging Systems Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 118
    Pathology imaging system uses the latest technology of scanners and software for digitizing the slides for pathological examinations. It has replaced the traditional pathology workflow of slides and microscope. Scope of the Report: The worldwide market for Pathology Imaging Systems is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study. ......
  • Global Patients Handling Equipment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Patient handling equipment market is expected to witness significant growth due to growing acceptance of these equipment owing to their wide array of applications. Rising prevalence of disabilities and high adoption rate of these equipment to cater needs of patients has led their increased usage. Scope of the Report: The worldwide market for Patients Handling Equipment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs